{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T14:46:54Z","timestamp":1790952414650,"version":"4.1.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T00:00:00Z","timestamp":1563235200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T00:00:00Z","timestamp":1563235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["DA035331"],"award-info":[{"award-number":["DA035331"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI102623"],"award-info":[{"award-number":["AI102623"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Burroughs Wellcome Trust"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Harm Reduct J"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12954-019-0317-3","type":"journal-article","created":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T13:03:19Z","timestamp":1563282199000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Justice involvement patterns, overdose experiences, and naloxone knowledge among men and women in criminal justice diversion addiction treatment"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7022-6385","authenticated-orcid":false,"given":"Rachel E.","family":"Gicquelais","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Briana","family":"Mezuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Betsy","family":"Foxman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy S. B.","family":"Bohnert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,7,16]]},"reference":[{"issue":"50\u201351","key":"317_CR1","doi-asserted-by":"publisher","first-page":"1378","DOI":"10.15585\/mmwr.mm6450a3","volume":"64","author":"RA Rudd","year":"2016","unstructured":"Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in drug and opioid overdose deaths\u2014United States, 2000-2014. MMWR Morb Mortal Wkly Rep. 2016;64(50\u201351):1378\u201382.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"12","key":"317_CR2","doi-asserted-by":"publisher","first-page":"349","DOI":"10.15585\/mmwr.mm6712a1","volume":"67","author":"Puja Seth","year":"2018","unstructured":"Seth P, Scholl L, Rudd RA, Bacon S. Overdose deaths involving opioids, cocaine, and psychostimulants\u2014United States, 2015\u20132016. MMWR Morb Mortal Wkly Rep. 2018;67 [cited 2018 May 4]. Available from: \n                    https:\/\/www.cdc.gov\/mmwr\/volumes\/67\/wr\/mm6712a1.htm","journal-title":"MMWR. Morbidity and Mortality Weekly Report"},{"issue":"1\u20133","key":"317_CR3","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.drugalcdep.2011.07.018","volume":"120","author":"ASB Bohnert","year":"2012","unstructured":"Bohnert ASB, Tracy M, Galea S. Characteristics of drug users who witness many overdoses: implications for overdose prevention. Drug Alcohol Depend. 2012;120(1\u20133):168\u201373.","journal-title":"Drug Alcohol Depend"},{"key":"317_CR4","unstructured":"Lagisetty P, Bohnert A, Fendrick A. Meeting the opioid challenge: getting naloxone to those who need it most. Health Affairs Blog. 2018; [cited 2018 May 22]. Available from: \n                    https:\/\/www.healthaffairs.org\/do\/10.1377\/hblog20180510.164285\/full\/"},{"issue":"11","key":"317_CR5","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.2105\/AJPH.2015.302843a","volume":"105","author":"SS Martins","year":"2015","unstructured":"Martins SS, Sampson L, Cerd\u00e1 M, Galea S. Worldwide prevalence and trends in unintentional drug overdose: a systematic review of the literature. Am J Public Health. 2015;105(11):2373.","journal-title":"Am J Public Health"},{"key":"317_CR6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/j.drugalcdep.2014.12.009","volume":"148","author":"E Behar","year":"2015","unstructured":"Behar E, Santos G-M, Wheeler E, Rowe C, Coffin PO. Brief overdose education is sufficient for naloxone distribution to opioid users. Drug Alcohol Depend. 2015;148:209\u201312.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"317_CR7","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1080\/08897077.2015.1010032","volume":"36","author":"SR Mueller","year":"2015","unstructured":"Mueller SR, Walley AY, Calcaterra SL, Glanz JM, Binswanger IA. A review of opioid overdose prevention and naloxone prescribing: implications for translating community programming into clinical practice. Subst Abuse. 2015;36(2):240\u201353.","journal-title":"Subst Abuse"},{"issue":"7","key":"317_CR8","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1111\/add.13326","volume":"111","author":"R McDonald","year":"2016","unstructured":"McDonald R, Strang J. Are take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteria. Addict Abingdon Engl. 2016;111(7):1177\u201387.","journal-title":"Addict Abingdon Engl."},{"issue":"1","key":"317_CR9","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7326\/0003-4819-158-1-201301010-00003","volume":"158","author":"PO Coffin","year":"2013","unstructured":"Coffin PO, Sullivan SD. Cost-effectiveness of distributing naloxone to heroin users for lay overdose reversal. Ann Intern Med. 2013;158(1):1\u20139.","journal-title":"Ann Intern Med"},{"issue":"3","key":"317_CR10","doi-asserted-by":"publisher","first-page":"e133","DOI":"10.1016\/S2468-2667(17)30006-3","volume":"2","author":"J Uyei","year":"2017","unstructured":"Uyei J, Fiellin DA, Buchelli M, Rodriguez-Santana R, Braithwaite RS. Effects of naloxone distribution alone or in combination with addiction treatment with or without pre-exposure prophylaxis for HIV prevention in people who inject drugs: a cost-effectiveness modelling study. Lancet Public Health. 2017;2(3):e133\u201340.","journal-title":"Lancet Public Health"},{"key":"317_CR11","volume-title":"Facing addiction in America: the surgeon General\u2019s spotlight on opioids","author":"HHS (US Department of Health and Human Services Office of the Surgeon General)","year":"2018","unstructured":"HHS (US Department of Health and Human Services Office of the Surgeon General). Facing addiction in America: the surgeon General\u2019s spotlight on opioids. Washington, DC: HHS; 2018."},{"issue":"2","key":"317_CR12","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1056\/NEJMsa064115","volume":"356","author":"IA Binswanger","year":"2007","unstructured":"Binswanger IA, Stern MF, Deyo RA, Heagerty PJ, Cheadle A, Elmore JG, et al. Release from prison\u2014a high risk of death for former inmates. N Engl J Med. 2007;356(2):157\u201365.","journal-title":"N Engl J Med"},{"issue":"1","key":"317_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1108\/IJPH-08-2016-0039","volume":"13","author":"L Brinkley-Rubinstein","year":"2017","unstructured":"Brinkley-Rubinstein L, Cloud DH, Davis C, Zaller N, Delany-Brumsey A, Pope L, et al. Addressing excess risk of overdose among recently incarcerated people in the USA: harm reduction interventions in correctional settings. Int J Prison Health. 2017;13(1):25\u201331.","journal-title":"Int J Prison Health"},{"issue":"9","key":"317_CR14","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1111\/j.1360-0443.2010.02990.x","volume":"105","author":"ELC Merrall","year":"2010","unstructured":"Merrall ELC, Kariminia A, Binswanger IA, Hobbs MS, Farrell M, Marsden J, et al. Meta-analysis of drug-related deaths soon after release from prison. Addict Abingdon Engl. 2010;105(9):1545\u201354.","journal-title":"Addict Abingdon Engl."},{"issue":"12","key":"317_CR15","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1111\/j.1360-0443.2007.02025.x","volume":"102","author":"M Davoli","year":"2007","unstructured":"Davoli M, Bargagli AM, Perucci CA, Schifano P, Belleudi V, Hickman M, et al. Risk of fatal overdose during and after specialist drug treatment: the VEdeTTE study, a national multi-site prospective cohort study. Addict Abingdon Engl. 2007;102(12):1954\u20139.","journal-title":"Addict Abingdon Engl"},{"issue":"7396","key":"317_CR16","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1136\/bmj.326.7396.959","volume":"326","author":"J Strang","year":"2003","unstructured":"Strang J, McCambridge J, Best D, Beswick T, Bearn J, Rees S, et al. Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up study. BMJ. 2003;326(7396):959\u201360.","journal-title":"BMJ."},{"issue":"5","key":"317_CR17","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/add.13265","volume":"111","author":"SM Bird","year":"2016","unstructured":"Bird SM, McAuley A, Perry S, Hunter C. Effectiveness of Scotland\u2019s National Naloxone Programme for reducing opioid-related deaths: a before (2006-10) versus after (2011-13) comparison. Addict Abingdon Engl. 2016;111(5):883\u201391.","journal-title":"Addict Abingdon Engl"},{"issue":"3","key":"317_CR18","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1111\/add.13668","volume":"112","author":"MKB Parmar","year":"2017","unstructured":"Parmar MKB, Strang J, Choo L, Meade AM, Bird SM. Randomized controlled pilot trial of naloxone-on-release to prevent post-prison opioid overdose deaths. Addict Abingdon Engl. 2017;112(3):502\u201315.","journal-title":"Addict Abingdon Engl."},{"key":"317_CR19","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.addbeh.2018.02.024","volume":"86","author":"Lauren Brinkley-Rubinstein","year":"2018","unstructured":"Brinkley-Rubinstein L, Zaller N, Martino S, Cloud DH, McCauley E, Heise A, Seal D. Criminal justice continuum for opioid users at risk of overdose. Addict Behav. 2018;86:104\u201310.","journal-title":"Addictive Behaviors"},{"key":"317_CR20","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.drugpo.2017.05.015","volume":"46","author":"M Horton","year":"2017","unstructured":"Horton M, McDonald R, Green TC, Nielsen S, Strang J, Degenhardt L, et al. A mapping review of take-home naloxone for people released from correctional settings. Int J Drug Policy. 2017;46:7\u201316.","journal-title":"Int J Drug Policy"},{"issue":"5\u20136","key":"317_CR21","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1002\/bsl.2300","volume":"35","author":"D Abreu","year":"2017","unstructured":"Abreu D, Parker TW, Noether CD, Steadman HJ, Case B. Revising the paradigm for jail diversion for people with mental and substance use disorders: intercept 0. Behav Sci Law. 2017;35(5\u20136):380\u201395.","journal-title":"Behav Sci Law"},{"issue":"3","key":"317_CR22","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/S0740-5472(03)00123-5","volume":"25","author":"S Belenko","year":"2003","unstructured":"Belenko S, Logan TK. Delivering more effective treatment to adolescents: improving the juvenile drug court model. J Subst Abus Treat. 2003;25(3):189\u2013211.","journal-title":"J Subst Abus Treat"},{"issue":"2","key":"317_CR23","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1097\/HRP.0000000000000052","volume":"23","author":"Y-I Hser","year":"2015","unstructured":"Hser Y-I, Evans E, Grella C, Ling W, Anglin D. Long-term course of opioid addiction. Harv Rev Psychiatry. 2015;23(2):76\u201389.","journal-title":"Harv Rev Psychiatry"},{"issue":"5\u20136","key":"317_CR24","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/bsl.2303","volume":"35","author":"EL Johnston","year":"2017","unstructured":"Johnston EL. Retributive justifications for jail diversion of individuals with mental disorder. Behav Sci Law. 2017;35(5\u20136):396\u2013407.","journal-title":"Behav Sci Law"},{"issue":"4","key":"317_CR25","first-page":"461","volume":"37","author":"F Sirotich","year":"2009","unstructured":"Sirotich F. The criminal justice outcomes of jail diversion programs for persons with mental illness: a review of the evidence. J Am Acad Psychiatry Law Online. 2009;37(4):461\u201372.","journal-title":"J Am Acad Psychiatry Law Online"},{"issue":"4","key":"317_CR26","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.annemergmed.2009.05.004","volume":"54","author":"ASB Bohnert","year":"2009","unstructured":"Bohnert ASB, Tracy M, Galea S. Circumstances and witness characteristics associated with overdose fatality. Ann Emerg Med. 2009;54(4):618\u201324.","journal-title":"Ann Emerg Med"},{"issue":"1","key":"317_CR27","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.drugalcdep.2007.10.014","volume":"94","author":"A Hakansson","year":"2008","unstructured":"Hakansson A, Schlyter F, Berglund M. Factors associated with history of non-fatal overdose among opioid users in the Swedish criminal justice system. Drug Alcohol Depend. 2008;94(1):48\u201355.","journal-title":"Drug Alcohol Depend"},{"key":"317_CR28","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1016\/j.drugalcdep.2015.05.026","volume":"153","author":"KD Wagner","year":"2015","unstructured":"Wagner KD, Liu L, Davidson PJ, Cuevas-Mota J, Armenta RF, Garfein RS. Association between non-fatal opioid overdose and encounters with healthcare and criminal justice systems: identifying opportunities for intervention. Drug Alcohol Depend. 2015;153:215\u201320.","journal-title":"Drug Alcohol Depend"},{"issue":"4","key":"317_CR29","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1007\/s11524-017-0204-8","volume":"95","author":"J Lorvick","year":"2018","unstructured":"Lorvick J, Comfort M, Kral AH, Lambdin BH. Exploring lifetime accumulation of criminal justice involvement and associated health and social outcomes in a community-based sample of women who use drugs. J Urban Health Bull N Y Acad Med. 2018;95(4):584\u201393.","journal-title":"J Urban Health Bull N Y Acad Med"},{"key":"317_CR30","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.drugalcdep.2015.06.023","volume":"154","author":"JA Barocas","year":"2015","unstructured":"Barocas JA, Baker L, Hull SJ, Stokes S, Westergaard RP. High uptake of naloxone-based overdose prevention training among previously incarcerated syringe-exchange program participants. Drug Alcohol Depend. 2015;154:283\u20136.","journal-title":"Drug Alcohol Depend"},{"issue":"7","key":"317_CR31","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/s10654-007-9134-1","volume":"22","author":"A Kariminia","year":"2007","unstructured":"Kariminia A, Law MG, Butler TG, Corben SP, Levy MH, Kaldor JM, et al. Factors associated with mortality in a cohort of Australian prisoners. Eur J Epidemiol. 2007;22(7):417\u201328.","journal-title":"Eur J Epidemiol"},{"issue":"5","key":"317_CR32","first-page":"563","volume":"132","author":"S Nolan","year":"2017","unstructured":"Nolan S, Buxton J, Dobrer S, Dong H, Hayashi K, Milloy MJ, et al. Awareness, possession, and use of take-home naloxone among illicit drug users, Vancouver, British Columbia, 2014\u20132015. Public Health Rep Wash DC 1974. 2017;132(5):563\u20139.","journal-title":"Public Health Rep Wash DC 1974"},{"issue":"3","key":"317_CR33","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.annemergmed.2016.07.027","volume":"69","author":"A Kestler","year":"2017","unstructured":"Kestler A, Buxton J, Meckling G, Giesler A, Lee M, Fuller K, et al. Factors associated with participation in an emergency department\u2013based take-home naloxone program for at-risk opioid users. Ann Emerg Med. 2017;69(3):340\u20136.","journal-title":"Ann Emerg Med"},{"key":"317_CR34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.drugpo.2017.09.015","volume":"51","author":"SC Heavey","year":"2018","unstructured":"Heavey SC, Chang Y-P, Vest BM, Collins RL, Wieczorek W, Homish GG. \u2018I have it just in case\u2019\u2014naloxone access and changes in opioid use behaviours. Int J Drug Policy. 2018;51:27\u201335.","journal-title":"Int J Drug Policy."},{"issue":"1","key":"317_CR35","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/ADM.0000000000000451","volume":"13","author":"Anne C. Fernandez","year":"2019","unstructured":"Fernandez AC, Bush C, Bonar EE, Blow FC, Walton MA, Bohnert ASB. Alcohol and drug overdose and the influence of pain conditions in an addiction treatment sample. J Addict Med. 2019;13(1):61-8.","journal-title":"Journal of Addiction Medicine"},{"issue":"2","key":"317_CR36","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.drugalcdep.2005.01.010","volume":"79","author":"M Tracy","year":"2005","unstructured":"Tracy M, Piper TM, Ompad D, Bucciarelli A, Coffin PO, Vlahov D, et al. Circumstances of witnessed drug overdose in new York City: implications for intervention. Drug Alcohol Depend. 2005;79(2):181\u201390.","journal-title":"Drug Alcohol Depend"},{"issue":"1\u20132","key":"317_CR37","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.pain.2007.01.014","volume":"130","author":"SF Butler","year":"2007","unstructured":"Butler SF, Budman SH, Fernandez KC, Houle B, Benoit C, Katz N, et al. Development and validation of the current opioid misuse measure. Pain. 2007 Jul;130(1\u20132):144\u201356.","journal-title":"Pain."},{"key":"317_CR38","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.jsat.2015.02.007","volume":"55","author":"L Ashrafioun","year":"2015","unstructured":"Ashrafioun L, Bohnert ASB, Jannausch M, Ilgen MA. Evaluation of the current opioid misuse measure among substance use disorder treatment patients. J Subst Abus Treat. 2015;55:15\u201320.","journal-title":"J Subst Abus Treat"},{"issue":"4","key":"317_CR39","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1080\/10705510701575602","volume":"14","author":"ST Lanza","year":"2007","unstructured":"Lanza ST, Collins LM, Lemmon DR, Schafer JL. PROC LCA: a SAS procedure for latent class analysis. Struct Equ Model Multidiscip J. 2007;14(4):671\u201394.","journal-title":"Struct Equ Model Multidiscip J"},{"issue":"1","key":"317_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07418820902926197","volume":"27","author":"JK Doerner","year":"2010","unstructured":"Doerner JK, Demuth S. The independent and joint effects of race\/ethnicity, gender, and age on sentencing outcomes in U.S. Federal Courts. Justice Q. 2010;27(1):1\u201327.","journal-title":"Justice Q"},{"issue":"7","key":"317_CR41","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1093\/aje\/kwh090","volume":"159","author":"G Zou","year":"2004","unstructured":"Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702\u20136.","journal-title":"Am J Epidemiol"},{"issue":"5","key":"317_CR42","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1093\/ije\/dyv137","volume":"44","author":"DB Richardson","year":"2015","unstructured":"Richardson DB, Kinlaw AC, MacLehose RF, Cole SR. Standardized binomial models for risk or prevalence ratios and differences. Int J Epidemiol. 2015;44(5):1660\u201372.","journal-title":"Int J Epidemiol"},{"issue":"4","key":"317_CR43","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1111\/dar.12644","volume":"37","author":"PM Dietze","year":"2018","unstructured":"Dietze PM, Stare M, Cogger S, Nambiar D, Olsen A, Burns L, et al. Knowledge of naloxone and take-home naloxone programs among a sample of people who inject drugs in Australia: variations across capital cities. Drug Alcohol Rev. 2018;37(4):457\u201363.","journal-title":"Drug Alcohol Rev"},{"key":"317_CR44","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.drugpo.2018.07.003","volume":"59","author":"K Tobin","year":"2018","unstructured":"Tobin K, Clyde C, Davey-Rothwell M, Latkin C. Awareness and access to naloxone necessary but not sufficient: examining gaps in the naloxone cascade. Int J Drug Policy. 2018;59:94\u20137.","journal-title":"Int J Drug Policy"},{"issue":"440","key":"317_CR45","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1080\/01621459.1997.10473658","volume":"92","author":"K Bandeen-Roche","year":"1997","unstructured":"Bandeen-Roche K, Miglioretti DL, Zeger SL, Rathouz PJ. Latent variable regression for multiple discrete outcomes. J Am Stat Assoc. 1997;92(440):1375\u201386.","journal-title":"J Am Stat Assoc"},{"key":"317_CR46","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1002\/9780470316696","volume-title":"Multiple imputation for nonresponse in surveys","author":"DB Rubin","year":"1987","unstructured":"Rubin DB. Multiple imputation for nonresponse in surveys. New York: Wiley; 1987. p. 326."},{"key":"317_CR47","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jsat.2016.07.005","volume":"69","author":"H Kirane","year":"2016","unstructured":"Kirane H, Ketteringham M, Bereket S, Dima R, Basta A, Mendoza S, et al. Awareness and attitudes toward intranasal naloxone rescue for opioid overdose prevention. J Subst Abus Treat. 2016;69:44\u20139.","journal-title":"J Subst Abus Treat"},{"issue":"2","key":"317_CR48","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1093\/jurban\/jtg025","volume":"80","author":"KE Tobin","year":"2003","unstructured":"Tobin KE, Latkin CA. The relationship between depressive symptoms and nonfatal overdose among a sample of drug users in Baltimore, Maryland. J Urban Health Bull N Y Acad Med. 2003;80(2):220\u20139.","journal-title":"J Urban Health Bull N Y Acad Med"},{"issue":"48","key":"317_CR49","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.15585\/mmwr.mm6448a3","volume":"64","author":"DC Des Jarlais","year":"2015","unstructured":"Des Jarlais DC, Nugent A, Solberg A, Feelemyer J, Mermin J, Holtzman D. Syringe service programs for persons who inject drugs in urban, suburban, and rural areas\u2014United States, 2013. MMWR Morb Mortal Wkly Rep. 2015;64(48):1337\u201341.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"23","key":"317_CR50","first-page":"631","volume":"64","author":"E Wheeler","year":"2015","unstructured":"Wheeler E, Jones TS, Gilbert MK, Davidson PJ. Centers for Disease Control and Prevention (CDC). Opioid overdose prevention programs providing naloxone to laypersons\u2014United States, 2014. MMWR Morb Mortal Wkly Rep. 2015;64(23):631\u20135.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"317_CR51","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jsat.2011.02.003","volume":"41","author":"AM Price","year":"2011","unstructured":"Price AM, Ilgen MA, Bohnert ASB. Prevalence and correlates of nonmedical use of prescription opioids in patients seen in a residential drug and alcohol treatment program. J Subst Abus Treat. 2011;41(2):208\u201314.","journal-title":"J Subst Abus Treat"},{"issue":"3","key":"317_CR52","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1016\/j.addbeh.2012.11.005","volume":"38","author":"ASB Bohnert","year":"2013","unstructured":"Bohnert ASB, Eisenberg A, Whiteside L, Price A, McCabe SE, Ilgen MA. Prescription opioid use among addictions treatment patients: nonmedical use for pain relief vs. other forms of nonmedical use. Addict Behav. 2013;38(3):1776\u201381.","journal-title":"Addict Behav"},{"issue":"1","key":"317_CR53","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1093\/pan\/mph001","volume":"12","author":"A Bolck","year":"2004","unstructured":"Bolck A, Croon M, Hagenaars J. Estimating latent structure models with categorical variables: one-step versus three-step estimators. Polit Anal. 2004;12(1):3\u201327.","journal-title":"Polit Anal"},{"key":"317_CR54","unstructured":"Clark S, Muth\u00e9n B. Relating latent class analysis results to variables not included in the analysis. Los Angeles: University of California; 2009. [cited 2018 May 3]. Available from: \n                    https:\/\/www.statmodel.com\/download\/relatinglca.pdf\n                    \n                  ."},{"issue":"4","key":"317_CR55","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1093\/pan\/mpq025","volume":"18","author":"J Vermunt","year":"2010","unstructured":"Vermunt J. Latent class modeling with covariates: two improved three-step approaches. Polit Anal. 2010;18(4):450\u201369.","journal-title":"Polit Anal"}],"container-title":["Harm Reduction Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-019-0317-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12954-019-0317-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12954-019-0317-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T23:21:55Z","timestamp":1594768915000},"score":1,"resource":{"primary":{"URL":"https:\/\/harmreductionjournal.biomedcentral.com\/articles\/10.1186\/s12954-019-0317-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,16]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["317"],"URL":"https:\/\/doi.org\/10.1186\/s12954-019-0317-3","relation":{},"ISSN":["1477-7517"],"issn-type":[{"value":"1477-7517","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,16]]},"assertion":[{"value":"16 May 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The University of Michigan Institutional Review Board approved the study protocol. Participants provided written informed consent.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was obtained.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"46"}}